Showing results (251-260 of 280) with videos related to

Sort By:
Pageof 28
Nature|February 16, 2017
Sterile protection against human malaria by chemoattenuated PfSPZ vaccineBenjamin Mordmüller, Güzin Surat, Heimo Lagler, et al.
Malaria Journal|March 25, 2022
Diagnostic performance and comparison of ultrasensitive and conventional rapid diagnostic test, thick blood smear and quantitative PCR for detection of low-density Plasmodium falciparum infections during a controlled human malaria infection study in Equatorial GuineaMaxmillian Mpina, Thomas C Stabler, Tobias Schindler, et al.
The Journal of Clinical Investigation|January 9, 2024
Safety and protective efficacy of PfSPZ Vaccine administered to HIV-negative and -positive Tanzanian adultsSaid Jongo, L W Preston Church, Florence Milando, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 30, 2019
Increase of Dose Associated With Decrease in Protection Against Controlled Human Malaria Infection by PfSPZ Vaccine in Tanzanian AdultsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
The American Journal of Tropical Medicine and Hygiene|November 17, 2017
Advancing Global Health through Development and Clinical Trials Partnerships: A Randomized, Placebo-Controlled, Double-Blind Assessment of Safety, Tolerability, and Immunogenicity of PfSPZ Vaccine for Malaria in Healthy Equatoguinean MenAlly Olotu, Vicente Urbano, Ali Hamad, et al.
The American Journal of Tropical Medicine and Hygiene|June 27, 2018
Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of Plasmodium falciparum Sporozoite Vaccine in Tanzanian AdultsSaid A Jongo, Seif A Shekalaghe, L W Preston Church, et al.
The American Journal of Tropical Medicine and Hygiene|April 18, 2019
Safety and Differential Antibody and T-Cell Responses to the Plasmodium falciparum Sporozoite Malaria Vaccine, PfSPZ Vaccine, by Age in Tanzanian Adults, Adolescents, Children, and InfantsSaid A Jongo, L W Preston Church, Ali T Mtoro, et al.
JCI Insight|April 30, 2024
Innate immune activation restricts priming and protective efficacy of the radiation-attenuated PfSPZ malaria vaccineLeetah Senkpeil, Jyoti Bhardwaj, Morgan R Little, et al.
Science Translational Medicine|May 22, 2020
A double-blind, placebo-controlled phase 1/2a trial of the genetically attenuated malaria vaccine PfSPZ-GA1Meta Roestenberg, Jona Walk, Saskia C van der Boor, et al.
Genome Medicine|January 10, 2020
Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potentialKara A Moser, Elliott F Drábek, Ankit Dwivedi, et al.
Pageof 28